Previous 10 | Next 10 |
3 Tips for Buying Penny Stocks as 2022 Comes to an End At the end of the year, those who trade penny stocks should make sure to review their investment strategies and portfolios. As the market is unpredictable, investors need to be prepared for any changes that may occur in the upcoming...
Are Penny Stocks Under $1 A Buy Now Or Too Risky? There’s no shortage of volatility in the stock market today. Whether you’re trading penny stocks or higher-priced names, wild swings are happening daily. But that doesn’t mean it’s time to head for the hil...
MINNEAPOLIS, Nov. 18, 2022 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), today announced that, effective November 15, 2022, the independent directors approved equity awards under Nuwellis’ 2021 Inducement Plan, as material inducements to seven individuals entering into employmen...
Nuwellis, Inc. (NUWE) Q3 2022 Earnings Conference Call November 08, 2022, 09:00 AM ET Company Participants Vivian Cervantes - IR Nestor Jaramillo - President & Chief Executive Officer Lynn Blake - CFO Conference Call Participants Jeff Cohen - Lade...
Nuwellis press release ( NASDAQ: NUWE ): Q3 GAAP EPS of -$0.37 misses by $0.05 . Revenue of $2.1M (+13.5% Y/Y) misses by $0.18M . Gross margin was 61.0% for the third quarter of 2022 compared to 60.4% in the prior-year period. Cash and cash equivalents were...
MINNEAPOLIS, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of people with fluid overload, today reported financial results for the third quarter ended September 30, 2022. Q3 Results and Recent Highligh...
MINNEAPOLIS, Nov. 03, 2022 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NasdaqCM: NUWE), a medical technology company focused on transforming the lives of people with fluid overload, today announced the publication of promising clinical data supporting the use of kidney replacement therapy with ...
MINNEAPOLIS, Oct. 19, 2022 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ: NUWE) announced today that its third quarter 2022 financial results will be released on Tuesday, November 8, 2022. The company will host a conference call and webcast at 9:00 AM ET, during which management will discuss t...
Nuwellis ( NASDAQ: NUWE ) has appointed Lynn Blake as Chief Financial Officer, effective October 19, 2022. Ms. Blake brings more than two decades of senior financial leadership experience, having served as a Managing Director at Growth Operators Advisory Services most rece...
MINNEAPOLIS, Oct. 19, 2022 (GLOBE NEWSWIRE) -- Continuing its commitment to expanding access to life-saving ultrafiltration therapies for adult and pediatric patients suffering from fluid overload, Nuwellis, Inc. (Nasdaq: NUWE) today announced the appointment of Lynn Blake as Chief ...
News, Short Squeeze, Breakout and More Instantly...
MINNEAPOLIS, July 23, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of people with fluid overload, today announced that it will release financial results for the second quarter of 2024 on Tuesday, August 13, 2024. Nuwellis w...
MINNEAPOLIS, July 17, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company dedicated to transforming the lives of patients suffering from fluid overload, is proud to announce its first commercial sale of QUELIMMUNE™, a novel therapy developed by SeaS...
DENVER, July 12, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU) (SeaStar Medical) reports the initial commercial sale of QUELIMMUNE ™ -Pediatric to its U.S. license and distribution partner, Nuwellis, Inc. QUELIMMUNE is SeaStar Medical’s Sel...